| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Clinical outcomes of non–small-cell lung cancer patients with BRAF mutations: results from the French Cooperative Thoracic Intergroup biomarkers France study
|
Couraud, Sébastien
|
|
2019
|
116 |
C |
p. 86-97
|
artikel
|
| 2 |
Effect of concomitant dosing with acid-reducing agents and vemurafenib dose on survival in patients with BRAFV600 mutation–positive metastatic melanoma treated with vemurafenib ± cobimetinib
|
Lewis, Karl
|
|
2019
|
116 |
C |
p. 45-55
|
artikel
|
| 3 |
Efficacy of PD-1–based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma
|
Kreft, Sophia
|
|
2019
|
116 |
C |
p. 207-215
|
artikel
|
| 4 |
Evaluation of needle biopsy as a potential risk factor for local recurrence of Wilms tumour in the SIOP WT 2001 trial
|
Irtan, Sabine
|
|
2019
|
116 |
C |
p. 13-20
|
artikel
|
| 5 |
Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumours: guidelines from the French national network dedicated to rare gynaecological cancers
|
Rousset-Jablonski, Christine
|
|
2019
|
116 |
C |
p. 35-44
|
artikel
|
| 6 |
Generalised morphea induced by pembrolizumab
|
Herrscher, Hugo
|
|
2019
|
116 |
C |
p. 178-181
|
artikel
|
| 7 |
High prevalence of severe hypovitaminosis D in patients with advanced gastric cancer treated with first-line chemotherapy with or without anti-EGFR–directed monoclonal antibody (EXPAND trial) showing no prognostic impact
|
Obermannova, Radka
|
|
2019
|
116 |
C |
p. 107-113
|
artikel
|
| 8 |
Human papillomavirus vaccination: The ESGO–EFC position paper of the European society of Gynaecologic Oncology and the European Federation for colposcopy
|
Joura, Elmar A.
|
|
2019
|
116 |
C |
p. 21-26
|
artikel
|
| 9 |
Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma
|
Howell, Jessica
|
|
2019
|
116 |
C |
p. 56-66
|
artikel
|
| 10 |
Immune-related adverse events predict the therapeutic efficacy of pembrolizumab in urothelial cancer patients
|
Kawai, Taketo
|
|
2019
|
116 |
C |
p. 114-115
|
artikel
|
| 11 |
Impact of comprehensive geriatric assessment on short-term mortality in older patients with cancer—a follow-up study
|
Ørum, Marianne
|
|
2019
|
116 |
C |
p. 27-34
|
artikel
|
| 12 |
Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group
|
Eder, T.
|
|
2019
|
116 |
C |
p. 67-76
|
artikel
|
| 13 |
Nivolumab plus ipilimumab versus chemotherapy as first-line treatment in advanced non–small-cell lung cancer with high tumour mutational burden: patient-reported outcomes results from the randomised, open-label, phase III CheckMate 227 trial
|
Reck, Martin
|
|
2019
|
116 |
C |
p. 137-147
|
artikel
|
| 14 |
No survival difference between robotic and open radical hysterectomy for women with early-stage cervical cancer: results from a nationwide population-based cohort study
|
Alfonzo, Emilia
|
|
2019
|
116 |
C |
p. 169-177
|
artikel
|
| 15 |
Pelvic Sentinel lymph node detection in High-Risk Endometrial Cancer (SHREC-trial)—the final step towards a paradigm shift in surgical staging
|
Persson, Jan
|
|
2019
|
116 |
C |
p. 77-85
|
artikel
|
| 16 |
Plasma AR status and cabazitaxel in heavily treated metastatic castration-resistant prostate cancer
|
Conteduca, Vincenza
|
|
2019
|
116 |
C |
p. 158-168
|
artikel
|
| 17 |
Probability of sentinel lymph node positivity in melanoma
|
El Sharouni, Mary-Ann
|
|
2019
|
116 |
C |
p. 10-12
|
artikel
|
| 18 |
Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma
|
Eggermont, Alexander M.M.
|
|
2019
|
116 |
C |
p. 148-157
|
artikel
|
| 19 |
Prognostic value of body composition on recurrence and survival of advanced-stage head and neck cancer
|
Jung, Ah Ra
|
|
2019
|
116 |
C |
p. 98-106
|
artikel
|
| 20 |
Reproductive factors associated with breast cancer risk in Li–Fraumeni syndrome
|
Khincha, Payal P.
|
|
2019
|
116 |
C |
p. 199-206
|
artikel
|
| 21 |
Survival of patients with non-small cell lung cancer having leptomeningeal metastases treated with immune checkpoint inhibitors
|
Hendriks, Lizza E.L.
|
|
2019
|
116 |
C |
p. 182-189
|
artikel
|
| 22 |
The added value of health-related quality of life as a prognostic indicator of overall survival and progression-free survival in glioma patients: a meta-analysis based on individual patient data from randomised controlled trials
|
Coomans, Marijke
|
|
2019
|
116 |
C |
p. 190-198
|
artikel
|
| 23 |
The gap in postoperative outcome between older and younger patients with stage I-III colorectal cancer has been bridged; results from the Netherlands cancer registry
|
Brouwer, Nelleke P.M.
|
|
2019
|
116 |
C |
p. 1-9
|
artikel
|
| 24 |
Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patients
|
Boyle, H.J.
|
|
2019
|
116 |
C |
p. 116-136
|
artikel
|
Tijdschrift beschrijving